Michael is the current CEO of Canexia Health and an accomplished B2B executive with a history of scaling global companies from startup, through acquisition and IPO. Prior to Canexia Health, he was the previous Global VP Informatics at Illumina, a $50B leader in the Genomics space. He was also the CEO of GenoLogics a venture backed start-up which was sold to Illumina. Michael served on the leadership team at Creo Products, during which time they executed a successful IPO. Michael is also active as an advisor and board member on companies in the Digital Health sector.